Cargando…

Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report

INTRODUCTION: Trastuzumab is generally considered a highly safe drug, but there have been cases of infusion reaction and cardiotoxicity. This report will present a rare case of hepatotoxicity induced by trastuzumab used for adjuvant therapy of human epidermal growth factor receptor type 2-positive b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishizuna, Kazuo, Ninomiya, Jun, Ogawa, Toshihisa, Tsuji, Eiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307619/ https://www.ncbi.nlm.nih.gov/pubmed/25491149 http://dx.doi.org/10.1186/1752-1947-8-417

Ejemplares similares

Efficacy of octreotide against chylothorax following lateral neck dissection for thyroid cancer: A case report
por: Hayashibara, Noriaki, et al.
Publicado: (2016)

Paclitaxel-resistant advanced recurrent breast cancer: a case of partial response due to addition of bevacizumab to paclitaxel therapy: a case report
por: Ishizuna, Kazuo, et al.
Publicado: (2013)

Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
por: Chung, Caroline, et al.
Publicado: (2009)

A case of breast cancer in the axillary tail of Spence – enhanced magnetic resonance imaging and positron emission tomography for diagnostic differentiation and preoperative treatment decision
por: Okubo, Mai, et al.
Publicado: (2013)

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group
por: Mackey, J.R., et al.
Publicado: (2008)

Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china
por: Xu, Qiaoping, et al.
Publicado: (2021)

Risk of hepatotoxicity with trastuzumab emtansine in breast cancer patients: a systematic review and meta-analysis
por: Cobert, Amani M., et al.
Publicado: (2020)

A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients
por: Matos, Erika, et al.
Publicado: (2016)

Antibacterials: Drug-induced hepatotoxicity: case report
Publicado: (2021)

Turmeric-Induced Hepatotoxicity: Report of 2 Cases
por: Sohal, Aalam, et al.
Publicado: (2021)

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK
por: Earl, H.M., et al.
Publicado: (2021)

Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
por: Ezaz, Ghideon, et al.
Publicado: (2014)

Antitubercular drugs: Drug-induced hepatotoxicity: case report
Publicado: (2022)

Voriconazole: Hepatotoxicity: case report
Publicado: (2021)

Cost-Effectiveness Analysis of Trastuzumab in the Adjuvant Treatment for Early Breast Cancer
por: Aboutorabi, Ali, et al.
Publicado: (2015)

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer
por: McLaughlin, Shannon, et al.
Publicado: (2023)

Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study
por: Li, Junjie, et al.
Publicado: (2018)

Dual HER2 Suppression with Lapatinib plus Trastuzumab for Metastatic Inflammatory Breast Cancer: A Case Report of Prolonged Stable Disease
por: Ogawa, Lauren, et al.
Publicado: (2018)

Trastuzumab treatment of invasive breast ductal carcinoma induces severe edema: a case report
por: Zhao, Hua, et al.
Publicado: (2022)

High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy
por: Katsurada, Kenichi, et al.
Publicado: (2014)

Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
por: Sardesai, Sagar, et al.
Publicado: (2020)

Hepatotoxicity induced by clozapine: a case report and review of literature
por: Wu Chou, Ana Isabel, et al.
Publicado: (2014)

Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports
por: Tsuda, Toyonobu, et al.
Publicado: (2018)

Anti-Tuberculosis Treatment: Induced Hepatotoxicity – A Case Report
por: Kumar, Poludasari Shravan, et al.
Publicado: (2020)

Colchicine-Induced Hepatotoxicity
por: Abbott, Collette E., et al.
Publicado: (2017)

Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
por: Zhou, Qiong, et al.
Publicado: (2020)

Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
por: Hingmire, Sachin S., et al.
Publicado: (2017)

Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
por: Joona, Therse Björkin, et al.
Publicado: (2020)

A Case of Supplement-Induced Hepatotoxicity
por: Cheng, Fong-Kuei Frank, et al.
Publicado: (2010)

Effectiveness of adjuvant trastuzumab in daily clinical practice
por: Matos, Erika, et al.
Publicado: (2014)

Adjuvant trastuzumab: progress, controversies, and the steps ahead
por: Joy, A.A., et al.
Publicado: (2006)

Garlic Extract Alleviates Trastuzumab-Induced Hepatotoxicity in Rats Through Its Antioxidant, Anti-Inflammatory, and Antihyperlipidemic Effects
por: Mousa, Ayman M, et al.
Publicado: (2021)

Trastuzumab-Associated Flagellate Erythema: Report in a Woman with Metastatic Breast Cancer and Review of Antineoplastic Therapy-Induced Flagellate Dermatoses
por: Cohen, Philip R.
Publicado: (2015)

Effectiveness of trastuzumab as adjuvant therapy in patients with early stage breast cancer: A systematic review and meta-analysis
por: Davari, Majid, et al.
Publicado: (2017)

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
por: Genuino, Anne Julienne, et al.
Publicado: (2019)

Rapid bupropion-induced hepatotoxicity: a case report and review of the literature
por: Anandabaskaran, Sulakchanan, et al.
Publicado: (2018)

Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag: a case report
por: Lattanzio, Mariangela, et al.
Publicado: (2022)

Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study
por: Blondeaux, Eva, et al.
Publicado: (2020)

Amiodarone/chloroquine/remdesivir interaction: Hepatotoxicity and off-label therapy: case report
Publicado: (2021)

Topical Diclofenac-Induced Hepatotoxicity
por: Delungahawatta, Thilini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u05l5fv78tbh6msacmsdhgg49r